Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Released: June 09, 2008
The use of dietary supplements has become increasingly popular among members of the military. While some supplements may provide benefits to health, others could carry adverse effects that might compromise the readiness and performance of service members. The U.S. Department of Defense, the Samueli Institute, the National Institutes of Health (NIH), with additional support from the Food and Drug Administration (FDA), requested that the Institute of Medicine (IOM) review the use of dietary supplements by military personnel, recommending a framework to identify the need for management of dietary supplement use within the military, and developing an approach to report adverse health events.
Released: April 25, 2008
Planning for an influenza pandemic, whether it occurs in the near or distant future, will need to take into account many constantly evolving factors. The Institute of Medicine (IOM) Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic was asked by the Department of Health and Human Services, (DHHS) to consider best practices and policies for providing antiviral treatment and prophylaxis during a pandemic event.
Released: April 11, 2008
The Institute of Medicine charged the ad hoc Committee on the Future Health Care Workforce for Older Americans to determine the health care needs of Americans over 65 years of age and to assess those needs through an analysis of the forces that shape the health care workforce, including education and training, models of care, and public and private programs. The resulting report, Retooling for an Aging America: Building the Health Care Workforce, says that as the population of seniors grows to comprise approximately 20 percent of the U.S. population, they will face a health care workforce that is too small and critically unprepared to meet their health needs.
Released: March 18, 2008
The Institute of Medicine’s Forum on Microbial Threats convened a workshop—on June 19-20, 2007, in Ft. Collins, CO—entitled Vector-Borne Diseases: Understanding the Environmental, Human Health, and Ecological Connections. The purpose of this public workshop was to examine the global burden of vector-borne diseases of humans, animals, and plants, and to discuss prospects for successful mitigation and response strategies.
Released: January 25, 2008
The current state of science in violence prevention reveals progress, promise, and a number of remaining challenges. In order to fully examine the issue of global violence prevention, the Institute of Medicine in collaboration with Global Violence Prevention Advocacy, convened a workshop and released the workshop summary entitled, Violence Prevention in Low-and Middle-Income Countries.
Released: January 24, 2008
Solutions to some of the nation’s most pressing health policy problems hinge on the ability to identify which diagnostic, treatment, and prevention services work best for various patients and circumstances. A new Institute of Medicine report, Knowing What Works in Health Care: A Roadmap for the Nation, provides a blueprint for a national program to assess the effectiveness of clinical services and to provide credible, unbiased information about what really works in health care.
Released: January 22, 2008
Schools of public health act as a resource by providing expertise to strengthen our nation's emergency response systems. In response to the Pandemic and All Hazards Preparedness Act (PAHPA) (Public Law 109–417, 2006, § 101 et seq.) there is an immediate and critical need to define research priorities for the Centers for Public Health Preparedness (CPHP) at schools of public health. It is because of this crucial need, that the Institute of Medicine (IOM) convened an ad hoc committee, conducted a fast-track study, and issued the letter report entitled Research Priorities in Emergency Preparedness and Response for Public Health Systems.
Released: January 08, 2008
The workshop brought together experts from multiple areas to discuss the most promising and practical arenas in neuroscience in which biomarkers will have the greatest impact. The main objective of the workshop was to identify and discuss biomarker targets that are not currently being aggressively pursued but that could have the greatest near-term impact on the rate at which new treatments are brought forward for psychiatric and neurological disorders.
Released: September 10, 2007
To better understand the types and magnitude of resources required to achieve the goals of the IOM report, the IOM’s Forum on Drug Discovery, Development, and Translation convened a 1-day symposium in March 2007. The symposium addressed the financial implications of many of the IOM’s recommendations, including strengthening the scientific base of the agency, integrating pre- and postmarket review, enhancing postmarket safety monitoring, conducting confirmatory drug safety and efficacy studies, improving clinical trial registration, and bolstering FDA’s regulatory and enforcement authority. The proceedings of the symposium are summarized in Challenges for the FDA: The Future of Drug Safety, Workshop Summary.
Released: May 23, 2007
Ending the Tobacco Problem generates a blueprint for the nation in the struggle to reduce tobacco use. The report reviews effective prevention and treatment interventions and considers a set of new tobacco control policies for adoption by federal and state governments.